Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Isotope & Radiation Corp. ( (HK:1763) ) has issued an announcement.
China Isotope & Radiation Corporation has announced proposed amendments to its Articles of Association, the Rules of Procedures of the Shareholders’ General Meeting, and the Rules of Procedures for the Board. These changes are in response to recent regulatory updates and are aimed at aligning the company’s governance documents with new legal and listing requirements. The amendments are subject to shareholder approval in upcoming meetings, and are intended to ensure compliance with evolving regulations, potentially impacting the company’s operational governance and stakeholder engagement.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation operates in the medical and industrial isotope and radiation industry, focusing on the production and distribution of isotopes and radiation-related products and services. The company is a key player in the Chinese market, providing essential materials and technologies for medical diagnostics, treatment, and industrial applications.
YTD Price Performance: 20.63%
Average Trading Volume: 171,320
Technical Sentiment Signal: Sell
Current Market Cap: HK$4.19B
Find detailed analytics on 1763 stock on TipRanks’ Stock Analysis page.